thalidomide has been researched along with Anterior Circulation Transient Ischemic Attack in 4 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "She developed transient ischemic attack after the introduction of lenalidomide plus dexamethasone (Rd) therapy despite no vascular risk factors." | 1.48 | Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome. ( Hashida, H; Hatano, K; Irie, K; Matsumoto, H; Mitsutake, A; Tsukada, N, 2018) |
| "Patients with multiple myeloma (MM) are at increased risk of arterial thrombosis." | 1.43 | Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study. ( Hinduja, A; Limaye, K; Papanikolaou, X; Ravilla, R; Sasapu, A; Torbey, M; Waheed, S; Wei, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitsutake, A | 1 |
| Matsumoto, H | 1 |
| Hatano, K | 1 |
| Irie, K | 1 |
| Tsukada, N | 1 |
| Hashida, H | 1 |
| Hauser, P | 1 |
| Vancsó, I | 1 |
| Pócza, T | 1 |
| Schuler, D | 1 |
| Garami, M | 1 |
| Akkoyun, M | 1 |
| Ardıç, I | 1 |
| Balakan, O | 1 |
| Deniz, MS | 1 |
| Acar, G | 1 |
| Hinduja, A | 1 |
| Limaye, K | 1 |
| Ravilla, R | 1 |
| Sasapu, A | 1 |
| Papanikolaou, X | 1 |
| Wei, L | 1 |
| Torbey, M | 1 |
| Waheed, S | 1 |
4 other studies available for thalidomide and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Topics: Adult; Brain; Brain Infarction; Dexamethasone; Female; Humans; Immunologic Factors; Ischemic Attack, | 2018 |
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemothera | 2013 |
Case images: Isolated thrombus-like mass in a patient with multiple myeloma.
Topics: Angiogenesis Inhibitors; Aorta; Diagnosis, Differential; Humans; Ischemic Attack, Transient; Male; M | 2014 |
Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study.
Topics: Acute Kidney Injury; Antineoplastic Agents; Case-Control Studies; Cerebral Hemorrhage; Hospital Mort | 2016 |